Stabilization of somatropin by heparin

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 5, 2005, Pages 555-564

  Zamiri, Camellia ^a,c   Groves, Michael J ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Protein Design Labs Inc ^*  (United States)

^c PROTEIN DESIGN LABS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; GLYCOSAMINOGLYCAN; HEPARIN; HISTIDINE; HUMAN GROWTH HORMONE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; LEVOTHYROXINE; LYSINE; STABILIZING AGENT; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISSOCIATION; DRUG BINDING SITE; DRUG EFFECT; DRUG FORMULATION; DRUG PROTEIN BINDING; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; FEMALE; HORMONE ACTION; HORMONE DETERMINATION; HYDRODYNAMICS; HYDROPHILICITY; HYPOPHYSECTOMY; IONIC STRENGTH; NONHUMAN; OPTICAL DENSITY; PARAMETER; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PROTEIN DENATURATION; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; RAT; RAT STRAIN; STOICHIOMETRY; STRUCTURE ANALYSIS; TECHNIQUE; TEMPERATURE DEPENDENCE; ULTRAVIOLET SPECTROSCOPY; WEIGHT GAIN;

ANIMALS; DRUG STABILITY; FEMALE; HEPARIN; HUMAN GROWTH HORMONE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOPHYSECTOMY; PARTICLE SIZE; PROTEIN DENATURATION; RATS; RATS, SPRAGUE-DAWLEY; TEMPERATURE; WEIGHT GAIN;

EID: 17644386823     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055975     Document Type: Article

References (40)

1. Ackland, C. E., Berndt, W. G., Frezza, J. E., Landgraf, B. E., Pritchard, K. W., Ciardelli, T. (1991) Monitoring of protein conformation by high-performance size-exclusion liquid chromatography and scanning diode array second derivative UV absorption spectroscopy. J. Chromatogr. 540: 187-198
2. American Association of Clinical Endocrinologists (2003) Medical guidelines for clinical practice for growth hormone use in adults and children - 2003 update. Endocr. Pract. 9: 64-76
3. Becker, G. W., Bowsher, R. R., Mackellar, W. C., Poor, M. L., Tackitt, P. M., Riggin, R. M. (1987) Chemical, physical, and biological characterization of biosynthetic human growth hormone. Biotechnol. Appl. Biochem. 9: 478-487
4. Bewley, T. A., Li, C. H. (1975) The chemistry of human pituitary growth hormone. Adv. Enzymol. Relat. Areas Mol. Biol. 42: 73-166
5. Bewley, T. A., Li, C. H. (1984) Conformational comparison of human pituitary growth hormone and human chorionic somatomammotropin (human placental lactogen) by second-order absorption spectroscopy. Arch. Biochem. Biophys. 233: 219-227
6. Brange, J. (2000) Physical stability of proteins. In: Hovgaard, L. (ed.) Pharmaceutical formulation development of peptides and proteins. Taylor & Francis, London, pp 89-112
7. Brems, D. N., Brown, P. L., Becker, G. W. (1990) Equilibrium denaturation of human growth-hormone and its cysteine-modified forms. J. Biol. Chem. 265: 5504-5511
8. Cardin, A. D., Weintraub, H. J. R. (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9: 21-32
9. Charman, S. A., Mason, K. L., Charman, W. N. (1993) Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone. Pharm. Res. 10: 954-962
10. Chen, B. L., Arakawa, T., Hsu, E., Narhi, L. O., Tressel, T. J., Chien, S. L. (1994) Strategies to suppress aggregation of recombinant keratinocyte growth-factor during liquid formulation development. J. Pharm. Sci. 83: 1657-1661
11. Chi, E. Y., Krishnan, S., Randolph, T. W., Carpenter, J. F. (2003) Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm. Res. 20: 1325-1336
12. Comper, W. D., Laurent, T. C. (1978) Physiological function of connective tissue polysaccharides. Physiol. Rev. 58: 255-315
13. Copeland, R. A., Ji, H., Halfpenny, A. J., Williams, R. W., Thompson, K. C., Herber, W. K., Thomas, K. A., Bruner, M. W., Ryan, J. A., Marquis-Omer, D., Sanyal, G., Sitrin, R. D., Yamazaki, S., Middaugh, C. R. (1991) The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch. Biochem. Biophys. 289: 53-61
14. Davio, S. R., Hageman, M. J. (1993) Characterization and formulation considerations for recombinantly derived bovine somatotropin. In: Pearlman, R. (ed.) Stability and characterization of protein and peptide drugs: case histories. Plenum Press, New York, pp 59-89
15. DeFelippis, M. R., Alter, L. A., Pekar, A. H., Havel, H. A., Brems, D. N. (1992) Evidence for a self-associating equilibrium intermediate during folding of human growth hormone. Biochemistry 32: 1555-1562
16. DeFelippis, M. R., Kilcomons, M. A., Lents, M. P., Youngman, K. M., Havel, H. A. (1995) Acid stabilization of human growth hormone equilibrium folding intermediates. Biochim. Biophys. Acta 1247: 35-45
17. Dill, K. A. (1990) Dominant forces in protein folding. Biochemistry 29: 7133-7155
18. Garcia, J. T., Dorta, M. J., Munguia, O., Llabres, M., Farina, J. B. (2002) Biodegradable laminar implants for sustained release of recombinant human growth hormone. Biomaterials 23: 4759-4764
19. Groesbeck, M. D., Parlow, A. F. (1987) Highly improved precision of the hypophysectomized female rat body weight gain bioassayl for growth hormone by increased frequency of injections, avoidance of antibody formation, and other simple modifications. Endocrinology 120: 2582-2590
20. Havel, H. A., Kauffman, E. W., Plaisted, S. M., Brems, D. N. (1986) Reversible self-association of bovine growth hormone during equilibrium unfolding. Biochemistry 25: 6533-6538
21. Havel, H. A., Chao, R. S., Haskell, R. J., Thamann, T. J. (1989) Investigations of protein structure with optical spectroscopy: bovine growth hormone. Anal. Chem. 61: 642-650
22. Jackson, R. L., Busch, S. J., Cardin, A. D. (1991) Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71: 481-539
23. Katakam, M., Banga, A. K. (1997) Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses. Pharm. Dev. Technol. 2: 143-149
24. Katakam, M., Bell, L., Banga, A. (1995) Effect of surfactants on the physical stability of recombinant human growth hormone. J. Pharm. Sci. 84: 713-716
25. Kidder, L. S., Schmidt, I. U., Evans, G. L., Turner, R. T. (1997) Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats. Calcif. Tissue Int. 61: 327-335
26. Maa, Y. F., Hsu, C. C. (1996) Membrane fouling in sterile filtration of recombinant human growth hormone. Biotechriol. Bioeng. 50: 319-328
27. Manning, M. C., Patel, K., Borchardt, R. T. (1989) Stability of protein pharmaceuticals. Pharm. Res. 6: 903-918
28. Mulkerrini M. G., Wetzel, R. (1989) pH-dependence of the reversible and irreversible thermal-denaturation of gamma-interferons. Biochemistry 28: 6556-6561
29. Mumunthaler, M., Hsu, C. C., Pearlman, R. (1994) Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator. Pharm. Res. 11: 12-20
30. Pearlman, R., Bewley, T. A. (1993) Stability and characterization of human growth hormone. In: Pearlman, R. (ed.) Stability and characterization of protein and peptide drugs: case histories. Plenum Press, New York, pp 1-58
31. Ragone, R., Colonna, G., Balestrieri, C, Servillo, L., Irace, G. (1984) Determination of tyrosine exposure in proteins by second-derivative spectroscopy. Biochemistry 23: 1871-1875
32. Rougeot, C., Marchand, P., Dary, F., Girard, F., Job, J. C., Pierson, M., Ponte, C., Rochiccoili, P., Rappaport, R. (1991) Comparative study of biosynthetic human growth hormone immunogenicity in growth hormone deficient children. Horm. Res. 35: 76-81
33. Schroeder-Tefft, J. A., Bentz, H., Estridge, T. D. (1997) Collagen and heparin matrices for growth factor delivery. J. Control. Release 49: 291-298
34. Scott, J. E. (1968) The chemical physiology of mucopolysaccharides. In: Quintarelli, G. (ed.) Ion binding in solutions containing acid mucopolysaccharides. Little, Brown, Boston, pp 171-187
35. Terada, H., Inoue, Y., Ichikawa, T. (1984) Second derivative spectral properties of tryptophan and tyrosine residues in proteins. Effects of guanidine hydrochloride and dodecyl sulfate on the residues in lysozyme, ribonuclease and serum albumin. Chem. Pharm. Bull. 32: 585-590
36. Timasheff, S. N. (1998) Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated. Adv. Protein Chem. 51: 355-432
37. Tsai, P. K., Volkin, D. B., Dabora, J. M., Thompson, K. C., Bruner, M. W., Gress, J. O., Matuszewska, B., Keogan, M., Bondi, J. V., Middaugh, C. R. (1993) Formulation design of acidic fibroblast growth-factor. Pharm. Res. 10: 649-659
38. Tsai, A. M., van Zanten, J. H., Betenbaugh, M. J. (1998) II. Electrostatic effect in the aggregation of heat-denatured RNase a and implications for protein additive design. Biotechnol. Bioeng, 59: 281-285
39. Volkin, D. B., Middaugh, C. R. (1996) The characterization, stabilization, and formulation of acidic fibroblast growth factor. Pharm. Biotechnol. 9: 181-217
40. Zamiri, C., Dadey, E. J. (2000) Preparation and characterization of novel, glycosaminoglycan-complexed human growth hormone formulations for improved bioavailability. American Association of Pharmaceutical Scientists, Annual Meeting. Indianapolis, IN. AAPS PharmSci, pp 1221